Last reviewed · How we verify
NCT07035522
Ozone Therapy for Women With Endometriosis
NA trial testing Ozone therapy in Endometriosis in 40 participants. Not yet recruiting.
20 December 2025
Quick facts
| Lead sponsor | Universidade Federal do Paraná |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 18 June 2025 |
| Primary completion | 20 December 2025 |
| Estimated completion | 20 December 2025 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Ozone therapy — full drug profile →
Conditions studied
- Endometriosis — all drugs for Endometriosis →
- Ozone Therapy — all drugs for Ozone Therapy →
- Thermography — all drugs for Thermography →
Sponsor
Universidade Federal do Paraná — full company profile →
Who can join
Adults 25 to 45, female only, with Endometriosis or Ozone Therapy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the action of ozone therapy as an adjuvant treatment in patients with endometriosis. Secondary Objective: To evaluate the efficacy of ozone therapy for pelvic analgesia in women with endometriosis; To compare the imaging diagnostic techniques of transvaginal ultrasound with infrared thermography in the pre-treatment (before), fourth, seventh and post-treatment (10th session) periods; To evaluate the application of the consolidated questionnaire (EHP-30) in the changes in the quality of life of the participants immediately after the intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07035522
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Ozone therapy
Trials testing the same drug.
- NCT07069153 — Laser vs Ozone Therapy for Oral Mucositis in Cancer Patients · NA · completed
- NCT06954870 — Effect of Systemic and Local Ozone Therapy in Lipedema · NA · completed
- NCT06706544 — Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy · Phase 2, PHASE3 · recruiting
- NCT06799351 — Gut Microbiome Profiles in Patients with Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544). · Phase 2, PHASE3 · recruiting
- NCT06631456 — Effects of Platelet-Rich Plasma and Ozone Therapy in Knee Osteoarthritis · completed
Other recruiting trials for Endometriosis
Currently open trials in the same condition.
- NCT06559852 — The Impact of Yoga on Endometriosis-Related Pain · NA · recruiting
- NCT07393295 — Efficacy and Tolerability of TENS in Endometriosis-related Pain · NA · recruiting
- NCT07134023 — Educational Program for the Multidisciplinary Support of Patients With Endometriosis · NA · recruiting
- NCT07240883 — ENDO1000 - A UK-wide Endometriosis Research Project · recruiting
- NCT06974773 — Remote Electrical Stimulation as a Long-term Intervention for Endometriosis Flare Ups · NA · recruiting
Other Universidade Federal do Paraná trials
Trials by the same sponsor.
- NCT05946330 — Nutritional Intervention IN Nash NON-ALCOHOLIC (NAFLD). · NA · unknown
- NCT06548893 — Acceptance and Commitment Therapy (ACT) in Groups for Obsessive Compulsive Disorder: A Clinical Trial in Brazil · NA · active not recruiting
- NCT03176537 — Periodontal Profile of Hypogonadic Men · Phase 4 · withdrawn
- NCT03216746 — Oral Health Educational Methods in Adolescence · NA · completed
- NCT03032848 — Vaginal Estrogens Comparative Trial on Pelvic Organ Prolapse Patients · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07035522 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidade Federal do Paraná
- Last refreshed: 25 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07035522.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing